Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.

Diğer sürümleri göster (1)

Factors that regulate the induction of apoptosis of tumour cells are potential candidates for therapeutic intervention for the majority of cancers. Studying modifiers of apoptotic responses, such as members of the tumour necrosis factor receptor superfamily, may give clues as to how induction of apo...

Detaylı Bibliyografya
Asıl Yazarlar:	Cross, N, Waterman, E, Jokonya, N, Fowles, A, Buckle, C, Phillips, J, Holen, I, Hamdy, F, Eaton, C
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2008

Benzer Materyaller

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells
Yazar:: Cross, N, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
Yazar:: Cross, N, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
Yazar:: Nyambo, R, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
Yazar:: Cross, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
Yazar:: Nyambo, R, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
Yazar:: Molokwu, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
Yazar:: Waterman, E, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
Yazar:: Holen, I, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
Yazar:: Eaton, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
Yazar:: Chandrasekharan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
Yazar:: Holen, I, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
Yazar:: Eaton, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
Yazar:: Papageorgiou, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
Yazar:: Bryant, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
Yazar:: Adeniji, O, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
Yazar:: Adeniji, O, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
Yazar:: Adeniji, O, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The role of osteoprotegerin in breast and prostate cancer
Yazar:: Holen, I, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
Yazar:: Darby, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

OPG is a survival factor for breast- and prostate cancer cells in vitro
Yazar:: Holen, I, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
Yazar:: Bryant, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
Yazar:: RACHANA eTRIVEDI, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.
Yazar:: Korie A Grayson, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
Yazar:: Phillips, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
Yazar:: Mitchell, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde
Yazar:: Lee Jae-Won, ve diğerleri
Baskı/Yayın Bilgisi: (2011-04-01)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
Yazar:: Cross, N, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
Yazar:: Oliver H. Voss, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

HIV induces TRAIL sensitivity in hepatocytes.
Yazar:: Challagundla K Babu, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis
Yazar:: Milot Julie, ve diğerleri
Baskı/Yayın Bilgisi: (2011-08-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2
Yazar:: Locklin, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
Yazar:: Glen, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
Yazar:: Masakatsu Oishi, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
Yazar:: L.A. Braga-Silva, ve diğerleri
Baskı/Yayın Bilgisi: (2009-08-01)

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Diurnal variation of non-specular meteor trails
Yazar:: J. Hinrichs, ve diğerleri
Baskı/Yayın Bilgisi: (2009-05-01)

Global variation of meteor trail plasma turbulence
Yazar:: L. P. Dyrud, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
Yazar:: Vikash Talreja, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)